Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice

Neuropharmacology(2020)10.1016/j.neuropharm.2020.108170Source: DataRank Database

Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice is a research paper published in Neuropharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.03)OA: greenTopics (64)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Lois S. Akinola ORCID,Joel E. Schlosburg ORCID,Aron H. Lichtman ORCID,Laura J. Sim‐Selley,Anu Mahadevan

Live enrichment

PubMed:32479813 PMC:PMC7529882 OpenAlex:https://openalex.org/W3032669879

NIGMS NIH HHS

Grant: R25 GM090084

NIDA NIH HHS

Grant: P50 DA005274

NIDA NIH HHS

Grant: R01 DA032246

NIDA NIH HHS

Grant: P30 DA033934

NIDA NIH HHS

Grant: R01 DA033760

National Institute on Drug Abuse

FWCI

1.03

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7529882

publisherhttps://api.elsevier.com/content/article/PII:S0028390820302380?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0028390820302380?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.neuropharm.2020.108170

Fields of Study

Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorNeuroscience of respiration and sleepAnimalsAnti-Anxiety AgentsArachidonic AcidsBenzodioxolesCannabinoid Receptor AgonistsConditioning, ClassicalEndocannabinoidsEnzyme InhibitorsGlyceridesMaleMiceMice, 129 StrainMice, Inbred C57BLMice, Inbred ICRMice, KnockoutMonoacylglycerol LipasesNicotinePiperidinesReceptor, Cannabinoid, CB1RewardTobacco Use Disorder

MeSH Terms

AnimalsArachidonic AcidsConditioning, ClassicalEnzyme InhibitorsGlyceridesMaleMice, Inbred C57BLMice, Inbred ICRMonoacylglycerol LipasesNicotinePiperidinesRewardTobacco Use DisorderAnti-Anxiety AgentsMice, KnockoutReceptor, Cannabinoid, CB1MiceBenzodioxolesMice, 129 StrainCannabinoid Receptor AgonistsEndocannabinoids

Keywords

Monoacylglycerol lipaseNicotineConditioned place preferenceEndocannabinoid systemPharmacologyRimonabantChemistryPsychologyCannabinoid receptorAddictionReceptorMedicineNeuroscienceBiochemistryAntagonistEndocannabinoidsMonoacylglycerol Lipase (Magl)Nicotine Reward2-Arachidonylglycerol (2-Ag)

Sustainable Development Goals

SDG 0: Good health and well-being